search
Graduate in Medicine and Surgery from the University of Valencia in 1993, with subsequent specialization in Gynecology and Obstetrics at the La Fe University Hospital in Valencia in 1998. Awarded a Doctorate in Medicine and Surgery from the Universitat de València in 2002, with a thesis titled "Vertical Transmission of HIV." Possesses extensive experience in biostatistics following the completion of the Statistical Methods in Health Sciences course at the Laboratory of Applied and Modeling Statistics, Autonomous University of Barcelona in 1995.
Currently a member of the Benign Gynecology Pathology Unit and the Functional Breast Unit at Bellvitge University Hospital and she serves as the supervisor for residents in the department. Since 2014, she has been an associate professor at the University of Barcelona, accredited by the AQU since 2019. In recent years, she has focused on the development of gynecological intervention guided by ultrasound for the puncture and sclerosis of low-risk ovarian cysts.
In terms of research, Dr. Garcia has participated in numerous national and international trials, notably serving as the principal investigator (PI) in a multicenter study titled "Evaluation of Ovarian Reserve After Treatment of Endometriomas by Sclerosis with Alcohol or Surgery Using Anti-Müllerian Hormone." This study is funded by the Carlos III Health Institute. It is worth mentioning that she also leads as PI a study on Radiofrequency Ablation of early-stage breast tumors. Another study focuses on reducing affected margins in conservative surgery for breast cancer, while another aims to validate selective axillary dissection (TAD) after neoadjuvant chemotherapy in locally advanced axillary breast cancer (N2) patients. Finally, her leadership in the multicenter study known as ADARNAT, comparing axillary lymphadenectomy to axillary radiotherapy in patients with positive sentinel nodes after neoadjuvant therapy, is noteworthy. This study is a randomized phase III multicenter trial.